Firebrick Pharma (ASX:FRE) Total Inventories : A$0.24 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Total Inventories?

Firebrick Pharma's total inventories for the quarter that ended in Jun. 2024 was A$0.24 Mil. Firebrick Pharma's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Jun. 2024 was A$0.26 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Firebrick Pharma's Net-Net Working Capital per share for the quarter that ended in Jun. 2024 was A$0.00.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Firebrick Pharma's Days Inventory for the six months ended in Jun. 2024 was 1,289.83.

Inventory Turnover measures how fast the company turns over its inventory within a year. Firebrick Pharma's Inventory Turnover for the quarter that ended in Jun. 2024 was 0.14.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Firebrick Pharma Total Inventories Historical Data

The historical data trend for Firebrick Pharma's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Total Inventories Chart

Firebrick Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Total Inventories

0.24

Firebrick Pharma Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23	Jun24
Total Inventories	-	-	-	0.28	0.24

Firebrick Pharma Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Firebrick Pharma (ASX:FRE) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Firebrick Pharma's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2024 is

	Net-Net Working Capital Per Share (Q: Jun. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.825	+	0.75 * 0.001	+	0.5 * 0.24	-	0.291
-	0	-	0)	/	195.307
=	0.00

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Firebrick Pharma's Days Inventory for the six months ended in Jun. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2024 )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
	=	0.2615	/	0.037	*	365 / 2
	=	1,289.83

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Firebrick Pharma's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2024 )	/	Average Total Inventories (Q: Jun. 2024 )
	=	0.037	/	0.2615
	=	0.14

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Firebrick Pharma's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	0.2615	/	-1.802
	=

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Firebrick Pharma Total Inventories Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Firebrick Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.firebrickpharma.com

Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.

Firebrick Pharma Headlines

No Headlines